COVID-19 and India: what next?

被引:1
|
作者
Behl, Ramesh [1 ]
Mishra, Manit [1 ]
机构
[1] Int Management Inst Bhubaneswar, Bhubaneswar, India
关键词
COVID-19; India; SIRD model; Basic reproduction number; Predictive modeling; Kaggle;
D O I
10.1108/IDD-08-2020-0098
中图分类号
G25 [图书馆学、图书馆事业]; G35 [情报学、情报工作];
学科分类号
1205 ; 120501 ;
摘要
Purpose - The study aims to carry out predictive modeling based on publicly available COVID-19 data for the duration April 01, 2020 to June 20, 2020 pertaining to India and five of its most infected states: Maharashtra, Tamil Nadu, Delhi, Gujarat and Rajasthan. Design/methodology/approach - The study leverages the susceptible, infected, recovered and dead (SIRD) epidemiological framework for predictive modeling. The basic reproduction number R0 is derived by an exponential growth method using RStudio package R0. The differential equations reflecting the SIRD model have been solved using Python 3.7.4 on the Jupyter Notebook platform. For visualization, Python Matplotlib 3.2.1 package is used. Findings - The study offers insights on peak-date, peak number of COVID-19 infections and end-date pertaining to India and five of its states. Practical implications - The results subtly indicate toward the amount of effort required to completely eliminate the infection. It could be leveraged by the political leadership and industry doyens for economic policy planning and execution. Originality/value - The emergence of a clear picture about COVID-19 lifecycle is impossible without integrating data science algorithms and epidemiology theoretical framework. This study amalgamates these two disciplines to undertake predictive modeling based on COVID-19 data from India and five of its states. Population-specific granular and objective assessment of key parameters such as reproduction number (RO), susceptible population (S), effective contact rate (B) and case-fatality rate (s) have been used to generate a visualization of COVID-19 lifecycle pattern for a critically affected population.
引用
收藏
页码:250 / 258
页数:9
相关论文
共 50 条
  • [2] Covid-19: what next?
    不详
    VETERINARY RECORD, 2020, 187 (02)
  • [3] COVID-19 and Italy: what next?
    Remuzzi, Andrea
    Remuzzi, Giuseppe
    LANCET, 2020, 395 (10231): : 1225 - 1228
  • [4] COVID-19: WHAT'S NEXT?
    Ponce-de-Leon, Alfredo
    Dolores Niembro-Ortega, Maria
    Gonzalez-Lara, Maria F.
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2021, 73 (05): : 329 - 334
  • [5] What next for covid-19 vaccines?
    Looi, Mun-Keat
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 379
  • [6] COVID-19: What Is Next for Portugal?
    Shaaban, Ahmed Nabil
    Peleteiro, Barbara
    Martins, Maria Rosario O.
    FRONTIERS IN PUBLIC HEALTH, 2020, 8
  • [7] COVID-19: What's next?
    Diaz Tasende, Jose
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2020, 43 (06): : 330 - 331
  • [8] What Is Next for COVID-19 Vaccination?
    Trilla, Antoni
    Trilla, Guillem
    Aldea, Marta
    Vilella, Anna
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2025,
  • [9] Immune response in COVID-19: what is next?
    Qing Li
    Ying Wang
    Qiang Sun
    Jasmin Knopf
    Martin Herrmann
    Liangyu Lin
    Jingting Jiang
    Changshun Shao
    Peishan Li
    Xiaozhou He
    Fei Hua
    Zubiao Niu
    Chaobing Ma
    Yichao Zhu
    Giuseppe Ippolito
    Mauro Piacentini
    Jerome Estaquier
    Sonia Melino
    Felix Daniel Weiss
    Emanuele Andreano
    Eicke Latz
    Joachim L. Schultze
    Rino Rappuoli
    Alberto Mantovani
    Tak Wah Mak
    Gerry Melino
    Yufang Shi
    Cell Death & Differentiation, 2022, 29 : 1107 - 1122
  • [10] COVID-19: what is next for public health?
    Heymann, David L.
    Shindo, Nahoko
    Bedford, Juliet
    Enria, Delia
    Giesecke, Johan
    Heymann, David
    Ihekweazu, Chikwe
    Kobinger, Gary
    Lane, Clifford
    Memish, Ziad
    Myoung-don, Oh
    Sall, Amadou Alpha
    Ungchusak, Kum
    Wieler, Lothar
    LANCET, 2020, 395 (10224): : 542 - 545